VIATRIS INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
VIATRIS INC. (VTRS) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax of -$78.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax · last filed 2026-02-26
- VIATRIS INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2025 was -$78.30M, a 194.11% decline from fiscal 2024.
- VIATRIS INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2024 was $83.20M, a 43.20% increase from fiscal 2023.
- VIATRIS INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2023 was $58.10M.
- VIATRIS INC. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2022 was -$82.10M, a 308.91% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month |
|---|---|
| 2025-12-31 | -$78.30M 10-K · filed 2026-02-26 |
| 2024-12-31 | $83.20M 10-K · filed 2026-02-26 |
| 2023-12-31 | $58.10M 10-K · filed 2026-02-26 |
| 2022-12-31 | -$82.10M 10-K · filed 2025-02-27 |
| 2021-12-31 | $39.30M 10-K · filed 2024-02-28 |
| 2020-12-31 | -$10.10M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |